Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zaizaoshengxue capsule in myelodysplastic syndrome
ChiCTR-IPR-16008973Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Aug 2016
- Countries
- 1
01
Overview
Phase 4, randomised trial of Zaizao Shengxue Jiaonang in myelodysplastic syndrome (MDS) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Hemoglobin level (Hb), Red blood cell count (RBC) and 4 more. Started Aug 2016; status: recruiting.
02
Drugs
Zaizao Shengxue Jiaonang
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on ChiCTR-IPR-16008973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008973.